KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Other Non-Current Liabilities (2016 - 2025)

Teladoc Health (TDOC) has disclosed Other Non-Current Liabilities for 12 consecutive years, with $643000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities fell 10.69% to $643000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $643000.0 through Dec 2025, down 10.69% year-over-year, with the annual reading at $643000.0 for FY2025, 10.69% down from the prior year.
  • Other Non-Current Liabilities hit $643000.0 in Q4 2025 for Teladoc Health, down from $4.2 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $4.3 million in Q1 2025 to a low of $643000.0 in Q4 2025.
  • Historically, Other Non-Current Liabilities has averaged $1.8 million across 5 years, with a median of $1.5 million in 2021.
  • Biggest five-year swings in Other Non-Current Liabilities: tumbled 86.49% in 2021 and later surged 475.68% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $1.5 million in 2021, then grew by 8.45% to $1.6 million in 2022, then tumbled by 33.25% to $1.1 million in 2023, then crashed by 33.33% to $720000.0 in 2024, then fell by 10.69% to $643000.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for TDOC at $643000.0 in Q4 2025, $4.2 million in Q3 2025, and $4.2 million in Q2 2025.